Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-03
2005-05-03
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S454000
Reexamination Certificate
active
06887883
ABSTRACT:
A series of compounds of natural origin are described, as useful agents for the treatment of diseases characterised by abnormal angiogenesis. These compounds are: chrysanthone A having formula (I); chrysanthone B having formula (II); and chrysanthone C having formula (III).
REFERENCES:
patent: 5843755 (1998-12-01), Obayashi et al.
patent: 0003726 (2000-01-01), None
Albinati et al, “Chrysanthone A Bioactive Alkaloid from Ascochyta-Chrysanthemi” PHYTOCHEMISTRY, vol. 28, No. 3, 1989, pp. 923-928.
Arnone et al, “Chrysanthones B and C Secondary Metabolites Produced by the Fugus Ascochyta-Chrysanthemi”, PHYTOCHEMISTRY, vol. 29, No. 8, 1990, pp. 2499-2502.
Assante et al, “Bioactive Secondary Metabolites from Some Mycosphaerella spp”, Rivista di Patologia Vegetale, vol. 4, No. 1, 1994, pp. 25-38.
Coval et al, “Pyrenoline A and B Two New Phytotoxins from Pyrenophora-Teres”, Tetrahedron Letters, vol. 31, No. 15, 1990, pp. 2117-2120.
Cook Rebecca
Nixon & Vanderhye P.C.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Use of natural chrysanthone compounds having antiangiogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of natural chrysanthone compounds having antiangiogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of natural chrysanthone compounds having antiangiogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3369753